<DOC>
	<DOCNO>NCT01129986</DOCNO>
	<brief_summary>An open-label , prospective , control , two-step approach , post-marketing clinical study , apply DermaStream saline streaming , conjunction sustain multi-compression wrap , healthy individual patient venous stasis ulcer low extremity .</brief_summary>
	<brief_title>A Post Marketing Clinical Study Utilizing DermaStream Saline Venous Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Group A : Must male female ≥18 year age . Must healthy individual intact skin Group B : Must male female ≥18 year age Must venous stasis ulcer knee ankle ( include lateral medial malleolus ) . The ulcer must typical appearance venous leg ulceration diagnosis venous origin . Ankle Brachial Pressure Index &gt; 0.8 &lt; =1.2 Must venous leg ulcer 3 cm 5.6 cm maximum ulcer duration 60 day great prior enrollment study Group A Group B : Is unable manage selftreatment home Is pregnant nursing mother Is woman child bear potential use adequate form contraception ( abstinent ) Is &lt; 18 year age With gross morbid obesity ( i.e. , Body Mass Index ≥ 50 ) Has know allergy drug and/or dressing part protocol Has previously participate study Group B : Has ulcer deem Investigator cause primarily medical condition venous insufficiency ( e.g. , diabetes , malignant ulceration [ Marjolin 's ulcer ] , vasculitis , etc . ) Has evidence current clinical infection although colonization exclusion criterion ( see definition section ) Suffers diabetes mellitus HbA1c ≥ 10 % Suffers clinically significant arterial disease Has evidence ulcer and/or infection extend underlying muscle , tendon , bone Has use investigational drug ( ) /device ( ) within 30 day precede screen physician subject anticipates use treatment 2 week follow start treatment portion study Has use anticipate use prohibit concomitant medication treatment , specify study protocol , section 9.1 . Suffers condition , venous insufficiency venous hypertension , opinion Investigator , would compromise safety subject and/or quality data . Suffers condition , venous insufficiency venous hypertension , opinion Investigator , would seriously interfere negatively normal wound heal process . Has laboratory value screen outside ± 20 % institution 's normal range parameter HbA1c If laboratory value outside ± 20 % investigator deem subject acceptable enrollment , Principal Investigator may approve inclusion subject long evidence comorbid condition comorbidity could influence trialIs use prohibit concomitant medication treatment . Wound surround skin intact sign active dermatitis infection Wound overbleeds Wound severely ischemic Wound large device aperture diameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>venous ulcer Dermastream</keyword>
</DOC>